Veterinary Medicines

Coglapix suspension for injection for pigs

Authorised
  • Actinobacillus pleuropneumoniae, APX III toxoid
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, APX II toxoid
Download as PDF

Product identification

Medicine name:
Coglapix suspension for injection for pigs
Coglapix инжекционна суспензия за прасета
Active substance:
  • Actinobacillus pleuropneumoniae, APX III toxoid
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, APX II toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Actinobacillus pleuropneumoniae, APX III toxoid
    6.80
    enzyme-linked immunosorbent assay unit/millilitre
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX I toxoid
    28.90
    enzyme-linked immunosorbent assay unit/millilitre
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX II toxoid
    16.70
    enzyme-linked immunosorbent assay unit/millilitre
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:
  • Cardboard box containing 5 vial of 100 ml
  • Cardboard box containing 1 vial of 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Animal Health Bulgaria EOOD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2373
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0120/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • Finland
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 3/06/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 3/06/2025
Download

Combined File of all Documents

English (PDF)
Published on: 27/08/2025
Download